Staffan Holmin´s research group
The Staffan Holmin research group is a part of the Department of Clinical Neuroscience at Karolinska Institutet and the Department of Neuroradiology at Karolinska University Hospital. The group is engaged in clinical and translational research on a wide variety of topics centered around modern neuroimaging, nuclear medicine, and image-guided vascular interventions.
Collaboration with Royal Institute of Technology
To enable technical development, we have extensive collaboration with researchers at the Department of Materials Science for prototyping and manufacture of novel endovascular equipment. We also have extensive collaboration with the research group Physics of Medical Imaging for the development of techniques in CT.
Clinical diagnostic and interventional neuroradiology
Clinical research is based at the Department of Neuroradiology at Karolinska University Hospital, and will continue at New Karolinska Hospital when the department relocates in 2018. Special areas of interest include pediatric neuroradiology, technical development in computed tomography (CT) and digital subtraction angiography, catheter-based chemotherapy in pediatric retinoblastoma, and thrombectomy in acute ischemic stroke.
Clinical and experimental radiochemistry
The work of prof emeritus Sharon Stone-Elander is continued in the group, where radiotracer development and validation, and positron emission tomography (PET) in animal models of stroke, inflammation and cancer are areas of study. The group also has a significant clinical responsibility of radiotracer production for Karolinska University Hospital as well as other hospitals in the region. Examples of produced radiotracers and areas of study include: 18F-FDG (glucose metabolism), 11C-methionine (amino acids), 11C-acetate (fatty acids), 18F-NAF (skeletal diseases), 18F-FLT (cell proliferation), 18F-FMISO (hypoxia), 68Ga-DOTATOC (NET/somatostatin receptor), 68Ga-PSMA (prostate cancer).
Our research projects
Exploration of “interventional nuclear medicine”, i.e. combination of endovascular intervention and nuclear medicine technology.
Developing of new diagnostic and therapeutic radiotracers
Evaluations of tracer utilization and metabolism in vitro and ex vivo
Pharmacokinetic evaluations of new PET imaging radiotracers in vivo in animal models of disease (cancer, brain, inflammation, apoptosis, hypoxia, cardiology) without and with therapeutic interventions
Experimental interventional radiology and imaging
At the KERIC core facility, preclinical and translational research is conducted using state-of-the-art imaging such as a full scale angiocatheterization lab for animal research, micro-PET for small animals, and high field 9.4T magnetic resonance imaging (MRI). New devices and applications for endovascular interventional technique are explored.
Clinically relevant stroke model
We have developed an endovascular stroke (M2CAO) model in rat, using standard clinical equipment, wherein selective M2 segment occlusion is achieved and can be modulated with reperfusion to simulate thrombectomy. The model could be considered a successor to the filament MCAO model, but with greater control over infarct size and with preserved collateral circulation. The model is coupled to longitudinal MRI and PET imaging.
Trans-vessel wall technique
We have developed a specialized catheter system that enables direct transvascular access to tissue for deposition of cells or substances, without risk of bleeding. The system is compatible with standard endovascular equipment and enables effective minimally invasive cell transplantation.
We are developing new techniques and devices for endovascular biopsy of the vessel wall and endothelium, heart, and other organs. These devices aim to be less traumatic, and suitable for downstream analysis of tissues and single cells using modern molecular biology, such as RNA-sequencing (RNA-seq).
Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications.
Acta Ophthalmol 2018 Dec;96(8):e1040-e1041
Treatment response assessment with (R)-[CPAQ PET in the MMTV-PyMT mouse model of breast cancer.
EJNMMI Res 2018 Apr;8(1):25
|Håkan Almqvist||Graduate Student|
|Arvin Chireh||PhD student|
|Anna Falk Delgado||Associated, Postdoc|
|Vamsi Krishna Gontu||Graduate Student|
|Rikard Grankvist||PhD student|
|Staffan Holmin||Research team leader, Professor/senior physician|
|Ida Jonsson||Research assistant|
|Emma Jussing||Graduate Student|
|Åsa Kuntze Söderqvist||Associated|
|Philip Little||Graduate Student|
|Daniel Martin Munoz||Graduate Student|
|Nuno Canto Moreira||Associated|
|Patrik Ring||Graduate Student|
|Erik Samén||Associated, Postdoc|
|Anki Sandberg Nordqvist||Associated|
|Mikael Sandell||Graduate Student|
|Sharon Stone-Elander||Professor emeritus|
|Fredrik Ståhl||Graduate Student|